Related Experiment Video
Updated: Jul 4, 2026
09:35
Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
Published on: April 20, 2021
Somatic hypermutation signature in B-cell low-grade lymphomas
Lorraine Tracey1, Mohit Aggarwal, Mónica García-Cosio
1Molecular Pathology Programme, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.
Haematologica
|June 17, 2008
Summary
Researchers identified a somatic hypermutation signature in small B-cell lymphomas. Protein markers RAD51C, CDK7, TFDP1, and POLA are linked to mutation status and survival, offering diagnostic potential.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Somatic hypermutation of immunoglobulin genes is a key prognostic factor in low-grade B-cell lymphomas.
- This includes chronic lymphocytic leukemia, mantle cell lymphoma, and splenic marginal zone lymphoma.
Purpose of the Study:
- To identify surrogate markers for somatic hypermutation in small B-cell lymphomas.
- To investigate the correlation between gene expression profiles and IgV(H) mutational status.
Main Methods:
- Analysis of IgV(H) mutational status and gene expression profiles in 93 small B-cell lymphoma samples.
- Protein expression analysis of selected genes (RAD51C, CDK7, TFDP1, POLA) using tissue microarrays in 118 cases.
- Evaluation of marker association with mutation status, ongoing mutation, and overall survival in mantle cell lymphoma.
Main Results:
- A somatic hypermutation signature involving genes in transcription, DNA repair, replication, and chromosome maintenance was identified.
- RAD51C and CDK7 protein expression strongly correlated with mutated status (p<0.003).
- TFDP1 and POLA expression associated with ongoing somatic hypermutation (p<0.001).
- RCC1 and CDK7 expression linked to longer overall survival in mantle cell lymphoma.
Conclusions:
- A distinct somatic hypermutation signature exists in small B-cell lymphomas.
- RAD51C, CDK7, TFDP1, and POLA serve as potential mechanistic and diagnostic markers.
- CDK7 and RCC1 expression may predict improved survival in mantle cell lymphoma.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...